Paolo Morandi

Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial

Luca Gianni, Tadeusz Pieńkowski, Young‐Hyuck Im et al. · The Lancet Oncology · 2011 · 2.3K citations

Breast Oncology, Oncology, Immunology +7

Breast Cancer Molecular Subtypes Respond Differently to Preoperative Chemotherapy

Roman Rouzier, Charles M. Perou, W. Fraser Symmans et al. · Clinical Cancer Research · 2005 · 1.9K citations · Full text

5-year analysis of neoadjuvant pertuzumab and trastuzumab in patients with locally advanced, inflammatory, or early-stage HER2-positive breast cancer (NeoSphere): a multicentre, open-label, phase 2 randomised trial

Luca Gianni, Tadeusz Pieńkowski, Young‐Hyuck Im et al. · The Lancet Oncology · 2016 · 846 citations

5-Year Analysis, Breast Oncology, Medicine +7

Performance of masonry buildings during the Emilia 2012 earthquake

Andrea Penna, Paolo Morandi, Maria Rota et al. · Bulletin of Earthquake Engineering · 2013 · 326 citations

Earthquake Engineering, Engineering, Masonry Structures +8

Damage Control for Clay Masonry Infills in the Design of RC Frame Structures

Sanja Hak, Paolo Morandi, Guido Magenes et al. · Journal of Earthquake Engineering · 2012 · 162 citations

Engineering, Masonry Structures, Structural Application +19